Omega-3 Blood Levels and Stroke Risk: A Pooled and Harmonized Analysis of 183 291 Participants From 29 Prospective Studies

Author:

O’Keefe James H.1ORCID,Tintle Nathan L.2,Harris William S.23,O’Keefe Evan L.1ORCID,Sala-Vila Aleix24,Attia John5ORCID,Garg G. Manohar5ORCID,Hure Alexis5ORCID,Bork Christian Sørensen6ORCID,Schmidt Erik Berg7ORCID,Venø Stine Krogh8,Chien Kuo-Liong9ORCID,Chen Yun-Yu (Amelia)10ORCID,Egert Sarah11,Feldreich Tobias Rudholm12,Ärnlöv Johan13ORCID,Lind Lars14ORCID,Forouhi Nita G.15ORCID,Geleijnse Johanna M.16ORCID,Pertiwi Kamalita16ORCID,Imamura Fumiaki15ORCID,de Mello Laaksonen Vanessa17ORCID,Uusitupa W. Matti17ORCID,Tuomilehto Jaakko17ORCID,Laakso Markku18ORCID,Lankinen Maria Anneli17ORCID,Laurin Danielle19ORCID,Carmichael Pierre-Hugues19ORCID,Lindsay Joan20,Leander Karin21ORCID,Laguzzi Federica21ORCID,Swenson Brenton R.22ORCID,Longstreth William T.23,Manson JoAnn E.24ORCID,Mora Samia24ORCID,Cook Nancy R.24ORCID,Marklund Matti252627ORCID,Melo van Lent Debora28ORCID,Murphy Rachel29ORCID,Gudnason Vilmundur30ORCID,Ninomiya Toshihara31,Hirakawa Yoichiro31,Qian Frank32ORCID,Sun Qi33ORCID,Hu Frank33ORCID,Ardisson Korat Andres V.34ORCID,Risérus Ulf35ORCID,Lázaro Iolanda4ORCID,Samieri Cecilia36,Le Goff Mélanie36ORCID,Helmer Catherine36,Steur Marinka37ORCID,Voortman Trudy37ORCID,Ikram M. Kamran37ORCID,Tanaka Toshiko38,Das Jayanta K.39,Ferrucci Luigi38ORCID,Bandinelli Stefania40,Tsai Michael41ORCID,Guan Weihua42ORCID,Garg Parveen43ORCID,Verschuren W.M. Monique4445ORCID,Boer Jolanda M.A.46ORCID,Biokstra Anneke46ORCID,Virtanen Jyrki17ORCID,Wagner Michael47ORCID,Westra Jason2,Albuisson Luc48,Yamagishi Kazumasa49ORCID,Siscovick David S.50ORCID,Lemaitre Rozenn N.51ORCID,Mozaffarian Dariush52ORCID

Affiliation:

1. Saint Luke’s Mid America Heart Institute, University of Missouri-Kansas City (J.H.O., E.L.O.).

2. Fatty Acid Research Institute (N.L.T., W.S.H., A.S.-V., J.W.), Sioux Falls, SD.

3. University of South Dakota (W.S.H.), Sioux Falls, SD.

4. Hospital del Mar Medical Research Institute, Barcelona, Spain (A.S.-V., I.L.).

5. The University of Newcastle, School of Biomedical Sciences and Pharmacy, Callaghan, Australia (J. Attia, G.M.G., A.H.).

6. Department of Cardiology, Aalborg University Hospital, Denmark (C.S.B.)

7. Department of Clinical Medicine (E.B.S.), Aalborg University Hospital, Denmark.

8. Department of Clinical Biochemistry (S.K.V.), Aalborg University Hospital, Denmark.

9. National Taiwan University, Institute of Epidemiology and Preventive Medicine, Taipei (K.-L.C.).

10. Department of Medical Research, Taichung Veterans General Hospital, Taiwan (Y.-Y.C.).

11. Institute of Nutrition and Food Sciences and Nutritional Physiology, University of Bonn, Germany (S.E.).

12. Dalarna University, School of Health and Welfare, Falun, Sweden (T.R.F.).

13. Division of Family Medicine and Primary Care, Department of Neurobiology Care Sciences and Society, Karolinska Institutet, Solna, Sweden (J. Ärnlöv).

14. Department of Medical Sciences Cardiovascular Epidemiology, Uppsala University, Sweden (L.L.).

15. MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, United Kingdom (N.G.F., F.I.).

16. Division of Human Nutrition and Health, Wageningen University and Research, the Netherlands (J.M.G., K.P.).

17. Institute of Public Health and Clinical Nutrition (V.d.M.L., W.M.U., J.T., M.A.L., J.V.), School of Medicine, University of Eastern Finland, Kuopio, Finland.

18. Department of Internal Medicine (M.L.), School of Medicine, University of Eastern Finland, Kuopio, Finland.

19. CHU de Québec-Université Laval and VITAM Research Centers, Centre d’Excellence sur le Vieillissement de Québec, Canada (D.L., P.-H.C.).

20. School of Epidemiology and Public Health, University of Ottawa, Canada (J.L.).

21. Karolinska Institutet, Institute of Environmental Medicine, Unit of Cardiovascular and Nutritional Epidemiology, Stockholm, Sweden (K.L., F.L.).

22. Cardiovascular Health Research Unit (B.R.S.), University of Washington, Seattle.

23. Departments of Neurology and Epidemiology (W.T.L.), University of Washington, Seattle.

24. Department of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA (J.E.M., S.M., N.R.C.).

25. The George Institute for Global Health, University of New South Wales, Newtown, Australia (M.M.).

26. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (M.M.).

27. Department of Public Health and Caring Sciences, Uppsala University, Sweden (M.M.).

28. Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, University of Texas, San Antonio (D.M.v.L.).

29. Cancer Control Research, British Columbia Cancer, School of Population and Public Health, University of British Columbia, Vancouver, Canada (R.M.).

30. Icelandic Heart Institute, Kopavogur, Iceland (V.G.).

31. Department of Epidemiology and Public Health and Center for Cohort Studies, Kyushu University, Fukouka, Japan (T.N., Y.H.).

32. Harvard Medical School, T.H. Chan School of Public Health and Beth Deaconess Medical Center, Boston, MA (F.Q.).

33. Harvard Medical School, T.H. Chan School of Public Health and Channing Division of Network Medicine Brigham and Women’s Hospital, Boston, MA (Q.S., F.H.).

34. USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA (A.V.A.K.).

35. Department of Public Health and Caring Sciences Clinical Nutrition and Metabolism Unit, Uppsala University, Sweden (U.R.).

36. Bordeaux Population Health Research Centre, University of Bordeaux, France (C.S., M.L.G., C.H.).

37. Department of Epidemiology, University Medical Center Rotterdam, the Netherlands (M.S., T.V., M.K.I.).

38. National Institutes of Health, National Institute on Aging, Longitudinal Studies Section, Baltimore, MD (T.T., L.F.).

39. Tata Medical Center, Kolkata, India (J.K.D.).

40. Azienda Sanitaria Firenze, Geriatric Unit, Florence, Italy (S.B.).

41. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis (M.T.).

42. Division of Biostatistics, University of Minnesota, Minneapolis (W.G.).

43. Department of Medicine, Cardiology, University of Southern California, Los Angeles (P.G.).

44. National Institute for Public Health and the Environment Bilthoven, the Netherlands (W.M.M.V.).

45. Julius Center for Health Sciences and Primary Care and Centre for Nutrition, Prevention and Health Services, Utrecht, the Netherlands (W.M.M.V.).

46. National Institute for Public Health and the Environment Bilthoven, the Netherlands (J.M.A.B., A.B.).

47. Departments of Neurodegenerative Diseases and Geriatric Psychiatry and German Center for Neurodegenerative Diseases, University Hospital, Bonn, Germany (M.W.).

48. University of Denver, CO (L.A.).

49. Department of Public Health Medicine, University of Tsukubu, Japan (K.Y.).

50. Department of Epidemiology, New York Academy of Medicine (D.S.S.).

51. Department of Medicine, University of Washington, Seattle (R.N.L.).

52. Division of Cardiology, Tufts University, Boston, MA (D.M.).

Abstract

BACKGROUND: The effect of marine omega-3 PUFAs on risk of stroke remains unclear. METHODS: We investigated the associations between circulating and tissue omega-3 PUFA levels and incident stroke (total, ischemic, and hemorrhagic) in 29 international prospective cohorts. Each site conducted a de novo individual-level analysis using a prespecified analytical protocol with defined exposures, covariates, analytical methods, and outcomes; the harmonized data from the studies were then centrally pooled. Multivariable-adjusted HRs and 95% CIs across omega-3 PUFA quintiles were computed for each stroke outcome. RESULTS: Among 183 291 study participants, there were 10 561 total strokes, 8220 ischemic strokes, and 1142 hemorrhagic strokes recorded over a median of 14.3 years follow-up. For eicosapentaenoic acid, comparing quintile 5 (Q5, highest) with quintile 1 (Q1, lowest), total stroke incidence was 17% lower (HR, 0.83 [CI, 0.76–0.91]; P <0.0001), and ischemic stroke was 18% lower (HR, 0.82 [CI, 0.74–0.91]; P <0.0001). For docosahexaenoic acid, comparing Q5 with Q1, there was a 12% lower incidence of total stroke (HR, 0.88 [CI, 0.81–0.96]; P =0.0001) and a 14% lower incidence of ischemic stroke (HR, 0.86 [CI, 0.78–0.95]; P =0.0001). Neither eicosapentaenoic acid nor docosahexaenoic acid was associated with a risk for hemorrhagic stroke. These associations were not modified by either baseline history of AF or prevalent CVD. CONCLUSIONS: Higher omega-3 PUFA levels are associated with lower risks of total and ischemic stroke but have no association with hemorrhagic stroke.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3